MA44972A - Procédés d'identification de modulateurs du cftr - Google Patents

Procédés d'identification de modulateurs du cftr

Info

Publication number
MA44972A
MA44972A MA044972A MA44972A MA44972A MA 44972 A MA44972 A MA 44972A MA 044972 A MA044972 A MA 044972A MA 44972 A MA44972 A MA 44972A MA 44972 A MA44972 A MA 44972A
Authority
MA
Morocco
Prior art keywords
identification processes
cftr modulator
modulator identification
cftr
processes
Prior art date
Application number
MA044972A
Other languages
English (en)
Inventor
Lawrence J Ii Drew
Po-Shun Lee
John Miller
Original Assignee
Proteostasis Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteostasis Therapeutics Inc filed Critical Proteostasis Therapeutics Inc
Publication of MA44972A publication Critical patent/MA44972A/fr

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/02Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/38Pediatrics
    • G01N2800/382Cystic fibrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MA044972A 2016-05-09 2017-05-09 Procédés d'identification de modulateurs du cftr MA44972A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662333537P 2016-05-09 2016-05-09

Publications (1)

Publication Number Publication Date
MA44972A true MA44972A (fr) 2019-03-20

Family

ID=58739383

Family Applications (1)

Application Number Title Priority Date Filing Date
MA044972A MA44972A (fr) 2016-05-09 2017-05-09 Procédés d'identification de modulateurs du cftr

Country Status (6)

Country Link
US (1) US20190154661A1 (fr)
EP (1) EP3455624A1 (fr)
AU (1) AU2017264612A1 (fr)
CA (1) CA3023512A1 (fr)
MA (1) MA44972A (fr)
WO (1) WO2017196843A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2988046A1 (fr) * 2015-06-02 2016-12-08 Abbvie S.A.R.L. Pyridines substituees et methode d'utilisation
US10548878B2 (en) 2015-07-24 2020-02-04 Proteostasis Therapeutics, Inc. Compounds, compositions, and methods of increasing CFTR activity
NZ741093A (en) 2015-10-06 2022-12-23 Proteostasis Therapeutics Inc Compounds, compositions, and methods for modulating cftr
BR112018070747B1 (pt) 2016-04-07 2024-01-09 Proteostasis Therapeutics, Inc Átomos de silicone contendo análogos de ivacaftor, composições farmacêuticas e usos terapêuticos
AU2017280206A1 (en) 2016-06-21 2019-01-17 Proteostasis Therapeutics, Inc. Compounds, compositions, and methods for increasing CFTR activity
EP3814336A1 (fr) 2018-06-27 2021-05-05 Proteostasis Therapeutics, Inc. Composés améliorant l'activité du protéasome

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010088630A2 (fr) * 2009-02-02 2010-08-05 Chromocell Corporation Lignées cellulaires exprimant cftr et procédés d'utilisation associés
HUE026271T2 (en) * 2010-09-14 2016-05-30 Inst Biochemii I Biofizyki Pan Mutant CFTR protein modulator compounds and their use for the treatment of diseases that interfere with CFTR protein function disorders
MX2015017532A (es) 2013-06-26 2016-10-26 Proteostasis Therapeutics Inc Métodos para modular la actividad del regulador de transmembrana de fibrosis quística.
US9745292B2 (en) 2014-03-13 2017-08-29 Proteostasis Therapeutics, Inc. Compounds, compositions, and methods for increasing CFTR activity
EP3116501A1 (fr) 2014-03-13 2017-01-18 Proteostasis Therapeutics, Inc. Composés, compositions et procédés pour augmenter l'activité du cftr
CA2952862A1 (fr) 2014-06-19 2015-12-23 Proteostasis Therapeutics, Inc. Composes, compositions et procedes pour augmenter l'activite du cftr
NZ741093A (en) 2015-10-06 2022-12-23 Proteostasis Therapeutics Inc Compounds, compositions, and methods for modulating cftr

Also Published As

Publication number Publication date
US20190154661A1 (en) 2019-05-23
WO2017196843A1 (fr) 2017-11-16
AU2017264612A1 (en) 2018-11-22
CA3023512A1 (fr) 2017-11-16
EP3455624A1 (fr) 2019-03-20

Similar Documents

Publication Publication Date Title
MA55748A (fr) Procédés de détection d'aav
SG10202105352UA (en) "identifying an entity"
MA44972A (fr) Procédés d'identification de modulateurs du cftr
MA41296A (fr) Procédés de transdifférenciation et procédés d'utilisation de ceux-ci
MA41298A (fr) Procédés de marquage de banques codées par de l'adn
MA48596A (fr) Caractéristique d'inertie
DE112015001987A5 (de) Vorrichtung zur Minderung von Wasserschall
FR3075439B1 (fr) Agregateur de dispositifs d'identification
MA49445A (fr) Buse multiliquide
DK3343570T3 (da) 68GE/68GA-generator
ES1162562Y (es) Brida de plástico.
MA46088A (fr) Procédés d'identification d'épitopes
FR3026520B1 (fr) Processus d'enregistrement de tracabilite
MA44639A (fr) Systèmes et procédés de qualité d'agrocarburant
UA34645S (uk) Малюнок для прапора
UA36012S (uk) Малюнок для етикетки
UA36323S (uk) Малюнок для етикетки
UA35666S (uk) Зображення для емблеми
UA34052S (uk) Малюнок для етикетки
UA34423S (uk) Малюнок для етикетки
UA34041S (uk) Малюнок для етикетки
UA35203S (uk) Малюнок для етикетки
UA34769S (uk) Малюнок для етикетки
UA32819S (uk) Малюнок для етикетки
UA33045S (uk) Малюнок для етикетки